Date: 19 Muharram 1444   Tuesday 16 August 2022

  • Last Update: Tuesday 16 August 2022، 08:12:05.

Pfizer estimates $54B from sale of COVID-19 vaccine, pills

09:24 09 February 2022 Author :  

US-based international pharmaceutical company Pfizer estimates a total of $54 billion revenue from its COVID-19 vaccine and oral pill sales this year, according to its financial results statement released Tuesday.

The company said it expects approximately $32 billion from vaccine doses to be delivered under its contracts signed as of late January.

An additional $22 billion revenue is expected from the company's antiviral coronavirus oral treatment pill Paxlovid.

Pfizer saw its revenue rise to $23.8 billion in the fourth quarter of 2021, soaring 105% from $11.6 billion in the same period of the previous year.

For the full year of 2021, revenue almost doubled to $81.3 billion from $41.6 billion in 2020, the financial results statement showed./aa

Read 1373

Related News:


Partly Cloudy



Partly Cloudy

Humidity: 75%

Wind: 30.58 km/h

  • 04 Jan 2019

    Sunny 18°C 12°C

  • 05 Jan 2019

    Mostly Sunny 17°C 11°C

  • Most Popular
  • Most Commented